Diabetes, Vol 41, Issue 8 1009-1015, Copyright © 1992 by American Diabetes Association

ARTICLES

Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose

M Maiello, D Boeri, F Podesta, E Cagliero, M Vichi, P Odetti, L Adezati and M Lorenzi
Department of Endocrinology and Metabolism, University of Genoa, Italy.

In diabetic patients, elevated plasma levels of t-PA and PAI-1 accompany impaired fibrinolysis. To identify mechanisms for these abnormalities, we examined whether vascular endothelial cells exposed to high glucose upregulate t-PA and PAI-1 production and whether ambient PA activity is decreased concomitantly. In 17 cultures of human umbilical vein endothelial cells grown to confluency in 30 mM glucose, the t-PA antigen released to the medium in 24 h was (median) 52 ng/10(6) cells (range 10-384) and the PAI-1 antigen was 872 ng/10(6) cells (range 217-2074)--both greater (P less than 0.02) than the amounts released by paired control cultures grown in 5 mM glucose--29 ng/10(6) cells (range 7.5-216) and 461 ng/10(6) cells (range 230-3215), respectively. In the presence of high glucose, the steady-state levels of t-PA and PAI-1 mRNAs were increased correspondingly (median 142 and 183% of control, respectively, P less than 0.05); high glucose per se and hypertonicity contributed to the upregulation in additive fashion. The PA activity of conditioned medium from cultures exposed to high glucose was 0.4 IU/ml (range 0.2-0.6), which was significantly lower (P less than 0.02) than the PA activity of control medium (0.5 IU/ml, range 0.2-0.9). No difference was observed when comparing the PA activities of acidified conditioned media, expected to be depleted of inhibitors. Thus, high glucose coordinately upregulates endothelial t-PA and PAI-1 expression through effects exerted at the pretranslational level and enhanced by even mild degrees of hypertonicity.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Brodsky, J. Chen, A. Lee, K. Akassoglou, J. Norman, and M. S. Goligorsky Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1784 - H1792. [Abstract] [Full Text] [PDF]

				A. Pandolfi, D. Cetrullo, R. Polishuck, M. M. Alberta, A. Calafiore, G. Pellegrini, E. Vitacolonna, F. Capani, and A. Consoli Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1378 - 1382. [Abstract] [Full Text] [PDF]

				J. Chen, S. Brodsky, H. Li, D. J. Hampel, T. Miyata, T. Weinstein, U. Gafter, J. T. Norman, L. G. Fine, and M. S. Goligorsky Delayed branching of endothelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1 Am J Physiol Renal Physiol, July 1, 2001; 281(1): F71 - F80. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden European Association for the Study of Diabetes Annual Meeting, 2000: Pathogenesis of type 2 diabetes, vascular disease, and neuropathy Diabetes Care, June 1, 2001; 24(6): 1115 - 1119. [Full Text]

				K. Minai, T. Matsumoto, H. Horie, N. Ohira, H. Takashima, H. Yokohama, and M. Kinoshita Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1565 - 1570. [Abstract] [Full Text] [PDF]

				M. B. Grant, P. E. Spoerri, D. W. Player, D. M. Bush, E. A. Ellis, S. Caballero, and W. G. Robison Plasminogen Activator Inhibitor (PAI)-1 Overexpression in Retinal Microvessels of PAI-1 Transgenic Mice Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2296 - 2302. [Abstract] [Full Text]

				H. P. Kohler and P. J. Grant Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease N. Engl. J. Med., June 15, 2000; 342(24): 1792 - 1801. [Full Text] [PDF]

				S. M Wileman, N. A Booth, N. Moore, B. Redmill, J. V Forrester, and R. M Knott Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells Br. J. Ophthalmol., April 1, 2000; 84(4): 417 - 422. [Abstract] [Full Text]

				Y.-Q. Chen, M. Su, R. R. Walia, Q. Hao, J. W. Covington, and D. E. Vaughan Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells J. Biol. Chem., April 3, 1998; 273(14): 8225 - 8231. [Abstract] [Full Text] [PDF]

				L. Byberg, A. Siegbahn, L. Berglund, P. McKeigue, R. Reneland, and H. Lithell Plasminogen Activator Inhibitor-1 Activity Is Independently Related to Both Insulin Sensitivity and Serum Triglycerides in 70-Year-Old Men Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 258 - 264. [Abstract] [Full Text] [PDF]